FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Acute Myeloid Leukemia Drug Development Guide

[ Price : $8.95]

FDA makes available a draft guidance entitled Acute Myeloid Leukemia: Developing Drugs and Biological Products for Treatment.

Draft Guide on Acute Myeloid Leukemia Drugs

[ Price : $8.95]

FDA makes available a draft guidance entitled Acute Myeloid Leukemia: Developing Drugs and Biological Products for Treatment.

FDA OKs Viltepso for Duchenne MD Mutation

[ Price : $8.95]

FDA approves NS Pharmas Viltepso to treat Duchenne muscular dystrophy patients with a specific confirmed gene mutation.

Covid Immunomodulatory Clinical Considerations

[ Price : $8.95]

CDER researchers describe efforts to develop immunomodulatory therapies for Covid-19.

Developing Male Breast Cancer Drugs

[ Price : $8.95]

FDA issues a guidance to help sponsors develop drugs to treat breast cancer in males.

Info Collection on Humanitarian Use Devices

[ Price : $8.95]

Federal Register notice: FDA seeks comments on an information collection entitled Medical Devices; Humanitarian Use Devices (HUD) ...

Info Collection on E-Records/E-Signatures

[ Price : $8.95]

Federal Register notice: FDA seeks comments on an information collection extension for electronic records and signatures.

Docs Should Reassure Covid Patients About FDA: Hahn

[ Price : $8.95]

FDA commissioner Stephen Hahn tries to reassure healthcare professionals that the agency is sticking to science and not cutting co...

Lantheus/Progenics sNDA Approved for Vialmix RFID

[ Price : $8.95]

FDA approves a Lantheus and Progenics Pharmaceuticals supplemental NDA for Vialmix RFID for Definity.

Alert on Compounded Moxifloxacin Ophthalmic Solutions

[ Price : $8.95]

An FDA drug safety alert warns about reports of toxic anterior segment syndrome following intraocular administration of compounded...